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Metabolic acidosis is common in patients with chronic kidney
disease (CKD) and may contribute to progression of CKD and
all-cause mortality [1]. However, little is known about how
CKD changes the response to an acute acid load and whether
an altered response could contribute to adverse outcomes [2].
Therefore, our aim was to characterize the differences between
the response to an acute oral acid load (to mimic the dietary
acid load) in patients with CKD and healthy subjects.
To do so, we performed the short acid-loading test with am-
monium chloride in 9 males with CKD Stage G4 and in 16
healthy male subjects (see Supplementary data for complete
methods and baseline characteristics) [3]. The study was ap-
proved by the Medical Ethics Committee (MEC-2016-329) and
registered at ClinicalTrials.gov (NCT03293446). In patients
with CKD, all antihypertensive drugs (except b-blockers) were
discontinued for 2 weeks to avoid drug interference. The test
started after an overnight fast by giving a 10% oral solution of
ammonium chloride (100 mg/kg body weight) over a period of
1 h together with a standardized meal (25 mmol sodium,
28 mmol potassium) and a water load (5 mL/kg followed by
2.5 mL/kg/h). The response to the acid load was observed for
6 h with repeated sampling of venous blood (at time 0, 3 and
6 h) and urine (hourly). Group comparisons were performed
using repeated-measures two-way analysis of variance.
At baseline, blood and urine pH and plasma bicarbonate of
the patients with CKD were significantly lower (Figure 1 and
Supplementary data, Figure S1). After 3 h, ammonium chloride
decreased blood pH and plasma bicarbonate and increased
plasma potassium and plasma aldosterone similarly in both
groups (Figure 1 and Supplementary data, Figure S1). At the
end of the test, however, blood pH, plasma potassium and
plasma aldosterone were returning to normal in the healthy
subjects but not in the patients. Plasma renin did not change
significantly during the test. The patients and healthy subjects
adequately lowered urine pH (<5.3 in all participants). The
healthy subjects and the patients also increased urine ammo-
nium excretion after 1 h, but the increase in healthy subjects
was significantly greater and persisted over time (Figure 1).
This resulted in a significantly lower cumulative ammonium ex-
cretion in patients (Supplementary data, Figure S1).
Accordingly, net acid excretion was also significantly lower in
patients (no difference in titratable acid; Supplementary data,
Figure S1). The same pattern as for urine ammonium excretion
was also observed for urine sodium, chloride and potassium ex-
cretion. The urine excretion of creatinine, albumin and the low
molecular weight proteins retinol-binding protein and renin
also acutely increased after the acid load, with normalization
thereafter (Figure 1 and Supplementary data, Figure S2). No
differences between the groups were observed for the courses in
creatinine and protein excretion, except for urinary renin. In
patients with CKD, systolic blood pressure fell during the first 2
h and increased thereafter, whereas it remained stable in the
healthy subjects (Supplementary data, Figure S2). Because
patients were significantly older than healthy subjects, we also
performed a subanalysis with older healthy subjects and found
similar results (data not shown).
Here we characterized the response to an acute acid load on
acid–base, electrolyte, creatinine and protein handling by the
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kidney and addressed whether this response is altered in
patients with CKD. We showed that urinary ammonium excre-
tion is reduced in patients with CKD, increasing the duration of
the acidosis. Of note, per-nephron ammonium excretion was
likely higher in patients with CKD, although this was not suffi-
cient to prevent the acidosis after acid loading. Persisting
FIGURE 1: Effects of an acute acid load with ammonium chloride on (A) venous blood pH and urine pH, (B) urine ammonium excretion,
(C) plasma potassium (Kþ), (D) plasma renin and aldosterone, (E) urine sodium excretion and cumulative excretion of sodium, chloride
and potassium, (F) urine creatinine excretion and (G) urine renin excretion. Group comparison was performed using repeated measures
two-way analysis of variance reporting the P-value for interaction. Cumulative excretions were compared with unpaired t-tests. Urine renin
was not normally distributed and was therefore log-transformed for analysis.
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acidaemia may have contributed to higher plasma potassium in
patients with CKD by decreasing sodium–hydrogen exchange
and sodium–potassium ATPase activity in cells [4].
Furthermore, cumulative potassium excretion was lower in
patients with CKD, which may also have contributed to the in-
crease in plasma potassium. Aldosterone was not a limiting fac-
tor for potassium secretion, as this increased in patients with
CKD. It is well characterized that metabolic acidosis induces
natriuresis initially [5–7], and we also observed this. In patients
with CKD, sodium excretion was lower, although—similar to
ammonium—per-nephron sodium excretion was likely higher.
Patients with CKD developed higher plasma aldosterone levels
after acid loading, with higher plasma potassium or acidosis as
potential drivers [8]. Another interesting observation was that
the acid load acutely increased the excretion of creatinine, albu-
min and low molecular weight proteins. This could be caused
by glomerular hyperfiltration or an effect on the proximal tu-
bule (decreased protein reabsorption, increased creatinine se-
cretion). We favour hyperfiltration as an explanation because
this was previously observed after ammonium chloride loading
in children [7] and rats [9] and because a previous micropunc-
ture study did not find evidence for inhibition of proximal
tubular reabsorption [6]. However, measurement of glomerular
filtration rate would have been necessary to differentiate be-
tween the two possibilities.
Our data add potential explanations why metabolic acidosis
in patients with CKD may contribute to adverse outcomes [2].
First, longer-lasting acidaemia causes a greater increase in
plasma potassium and will therefore increase susceptibility to
hyperkalaemia and its complications [10]. Second, the lower
pH and higher plasma potassium increase plasma aldosterone,
which may promote kidney fibrosis [11]. Third, acidosis
increases proteinuria, which has been identified as a risk factor
for progression of CKD [12]. Although this change also oc-
curred in healthy volunteers, the acid load exposes patients with
CKD to a greater degree of proteinuria, which may contribute
to further kidney injury. Moreover, the acid load did cause a
greater increase in urinary renin in patients than in healthy sub-
jects, indicating differences between individual proteins [13].
The limitation of this study is that we did not include measure-
ments of glomerular haemodynamics. Future studies are
needed to evaluate if the identified differences in the acute re-
sponse to acid loading also play a role in the long-term out-
comes of CKD. In summary, we show that CKD alters the
response to an acute acid load and we propose that this altered
response may explain some of the associations between meta-
bolic acidosis and outcomes in CKD.
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